GB1252373A - - Google Patents
Info
- Publication number
- GB1252373A GB1252373A GB1252373DA GB1252373A GB 1252373 A GB1252373 A GB 1252373A GB 1252373D A GB1252373D A GB 1252373DA GB 1252373 A GB1252373 A GB 1252373A
- Authority
- GB
- United Kingdom
- Prior art keywords
- chitin
- zinc
- depolymerised
- powder
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920002101 Chitin Polymers 0.000 abstract 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 abstract 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- QLTSDROPCWIKKY-PMCTYKHCSA-N beta-D-glucosaminyl-(1->4)-beta-D-glucosamine Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O1 QLTSDROPCWIKKY-PMCTYKHCSA-N 0.000 abstract 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 abstract 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 1
- 229960005091 chloramphenicol Drugs 0.000 abstract 1
- 238000001246 colloidal dispersion Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 abstract 1
- 229960004919 procaine Drugs 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 abstract 1
- 229940033663 thimerosal Drugs 0.000 abstract 1
- 229940056904 zinc ascorbate Drugs 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 abstract 1
- 229940057977 zinc stearate Drugs 0.000 abstract 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 abstract 1
- 235000009529 zinc sulphate Nutrition 0.000 abstract 1
- 239000011686 zinc sulphate Substances 0.000 abstract 1
- WWRJFSIRMWUMAE-ZZMNMWMASA-L zinc;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-olate Chemical compound [Zn+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] WWRJFSIRMWUMAE-ZZMNMWMASA-L 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB578169 | 1969-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1252373A true GB1252373A (cg-RX-API-DMAC7.html) | 1971-11-03 |
Family
ID=9802504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1252373D Expired GB1252373A (cg-RX-API-DMAC7.html) | 1969-02-03 | 1969-02-03 |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1252373A (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0086627A1 (en) * | 1982-02-12 | 1983-08-24 | Unitika Ltd. | Anti-cancer device |
| EP0105106A3 (en) * | 1982-08-30 | 1986-07-16 | Daito Koeki Kabushiki Kaisha | Anti-bacterial composition |
-
1969
- 1969-02-03 GB GB1252373D patent/GB1252373A/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0086627A1 (en) * | 1982-02-12 | 1983-08-24 | Unitika Ltd. | Anti-cancer device |
| EP0105106A3 (en) * | 1982-08-30 | 1986-07-16 | Daito Koeki Kabushiki Kaisha | Anti-bacterial composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1252207A (cg-RX-API-DMAC7.html) | ||
| GB1502895A (en) | Carotenoid preparations | |
| GB1241621A (en) | Wound healing composition | |
| GB1430634A (en) | Fibres of regenerated cellulose and polyacrylic acid salt of alkali-metals | |
| GB1499555A (en) | Topical vascular chemotherapy | |
| NO895112D0 (no) | Kosmetisk blanding. | |
| FR1586125A (cg-RX-API-DMAC7.html) | ||
| GB1251720A (cg-RX-API-DMAC7.html) | ||
| US1937365A (en) | Preparation for coloring hair | |
| GB1391013A (en) | Process for producing arsenic doped selenium | |
| GB1492917A (en) | Granules and powders for the preparation of ointments | |
| GB1435269A (en) | Substituted azobenzenes having liquid crystal properties | |
| GB1173226A (en) | Substituted 6,7-Benzomorphans and their Preparation | |
| GB1331190A (en) | X-ray contrast composition containing barium sulphate | |
| ES432208A1 (es) | Procedimiento para preparar aglomerados fuertes, estables y de libre fluencia de peroxido de carbonato sodico. | |
| GB1435630A (en) | Antipeptic ulcer composition | |
| US3737376A (en) | Non-dusting and moisture-resistant enzyme compositions | |
| GB1478449A (en) | Process for dispersing finely divided particles in an aqueous medium | |
| ES434688A1 (es) | Un metodo para preparar una tableta de una formulacion far- maceutica que contiene una 2, 4-diaminopirimidina y una sul-fonamida. | |
| GB1435993A (en) | Opaque regenerated cellulose for keeping | |
| CA984849A (en) | Metal complexes of n,n'-dialkylesters of ethylenedinitrilotetraacetic acid and compositions stabilized thereby | |
| ES8406538A1 (es) | Un procedimiento para fabricar un producto detergente organico sintetico en particulas. | |
| GB1189481A (en) | Stable Liquid Compositions of Matter | |
| GB668968A (en) | Colloidal iodine preparation and method of making the same | |
| CA923425A (en) | Compositions containing garcinia acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |